CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −3,080 | $31.58 | $97K | 1,518 |
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 225,063 | ||
| 2025-12-19 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 196,492 | ||
| 2025-12-11 | Martin Christopher Nathan Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-09-17 | Fairmount Funds Management LLC Director | Grant or award | +333,340 | $15.00 | $5.0M | 1,131,954 |
| 2025-07-01 | Sandler Laura Lee Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-02 | Fairmount Funds Management LLC Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-06-02 | Kulkarni Samarth Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-06-02 | Dambkowski Carl Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-06-02 | Turtle Cameron Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-06-02 | BALL KRISTINE M Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-02-14 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +88,794 | $11.44 | $1.0M | 4,148,428 |
| 2025-02-13 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +14,950 | $11.63 | $174K | 4,059,634 |
| 2025-02-12 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +8,971 | $11.86 | $106K | 4,044,684 |
| 2025-02-11 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +9,593 | $10.95 | $105K | 4,035,713 |
| 2025-02-10 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +574 | $10.90 | $6K | 4,026,120 |
| 2025-01-22 | Agarwal Arjun SVP, Finance | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2025-01-22 | Goncalves Joana Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +162,500 | 162,500 | ||
| 2025-01-22 | Quinlan Paul T General Counsel | Grant or award · Employee Stock Option (right to buy) | +162,500 | 162,500 | ||
| 2025-01-22 | Klein Lawrence Otto Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +230,000 | 230,000 |
Page 14 of 18 · 346 trades